SCHEMBL1992069

SCHEMBL1992069

Cc1ccc(C=Cc2cccc3c4c([nH]c23)CCN(C)C4)cn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 1/20 0.44
KDM4E B2RXH2 3/20 0.44
ALDH1A1 P00352 2/20 0.44
SIRT2 Q8IXJ6 1/20 0.40
HTR6 P50406 6/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HRH1 P35367 3/20 0.38
DRD2 P14416 2/20 0.38
DRD3 P35462 2/20 0.38
BCHE P06276 1/20 0.38
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
ACHE P22303 1/20 0.38
HRH2 P25021 1/20 0.38
ADRA1D P25100 1/20 0.38
HTR1D P28221 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
HTR1E P28566 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1992066 1.00 CHRNA7 (0.44) CHRNA7KDM4EALDH1A1SIRT2HTR6
SCHEMBL1990436 0.85 BAZ2B (0.49) CFTR
SCHEMBL1990437 0.85 BAZ2B (0.49) CFTR
SCHEMBL1988307 0.83 LMNA (0.48) KDM4EALDH1A1ALOX15HSD17B10POLB
SCHEMBL1988306 0.83 LMNA (0.48) KDM4EALDH1A1ALOX15HSD17B10POLB
SCHEMBL1986128 0.82 KMT2A (0.46) KDM4EALDH1A1DRD2DRD3HSD17B10
SCHEMBL1986126 0.82 KMT2A (0.46) KDM4EALDH1A1DRD2DRD3HSD17B10
SCHEMBL1987945 0.81 TAAR1 (0.47) KDM4ESIRT2HTR2AHTR2CHTR5A
SCHEMBL1987946 0.81 TAAR1 (0.47) KDM4ESIRT2HTR2AHTR2CHTR5A
SCHEMBL12561252 0.81 CHRNA7 (0.56) CHRNA7KDM4EALDH1A1SIRT2HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809532-B2 Aza-ring fused indole and indoline derivatives ABBVIE INC. (US) 2014-08-19 US claimed
US-20110152308-A1 AZA-RING FUSED INDOLE AND INDOLINE DERIVATIVES ABBOTT LABORATORIES (US) 2011-06-23 US claimed
US-8809532-B2 Aza-ring fused indole and indoline derivatives ABBVIE INC. (US) 2014-08-19 US disclosed
US-20110152308-A1 AZA-RING FUSED INDOLE AND INDOLINE DERIVATIVES ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152308-A1 AZA-RING FUSED INDOLE AND INDOLINE DERIVATIVES INMT, IDO1, IDO2 CHRNA7 601/4885KDM4E 326/4885ALDH1A1 231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.